Latest Cancer biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Células asesinas contra el cáncer de pulmón más agresivo

by CIMA - Centro de Investigación Médica Aplicada

9 months ago
linfocitos ‘natural killer’, CCL5, cáncer de pulmón

Investigadores del Cima Universidad de Navarra demuestran que una nueva estrategia para activar linfocitos ‘natural killer’ disminuye significativamente el tumor en modelos animales

A key genetic safeguard works differently across tissues and individuals

by IRB Barcelona - Instituto de Investigación Biomédica

9 months ago
Nonsense-Mediated mRNA Decay (NMD) pathway

The efficiency of the Nonsense-Mediated mRNA Decay (NMD) pathway, a genetic quality control mechanism, differs across human tissues and individuals.

A key mechanism discovered in mantle cell lymphoma opens the door to new treatments

by Fundació Clínic per a la Recerca Biomèdica

9 months ago
mantle cell lymphoma (MCL), SOX11, SMARCA4, PROTAC molecules

An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.

ORYZON strengthens patent portfolio for iadademstat with European grant decision covering combinations with PD1/PD-L1 inhibitors

by Oryzon Genomics

9 months ago
PD1 or PD-L1 inhibitors, Iadademstat, small cell lung cancer (SCLC), atezolizumab or durvalumab

Oryzon Genomics today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of iadademstat for cancer therapy...

Integrated DNA Technologies and Hamilton Partner to Automate Customizable NGS Workflows and Accelerate Biomarker Discovery

by Integrated DNA Technologies

Strategic partnership provides complete automation-friendly solution for IDT NGS workflows on Hamilton’s liquid handling systems and enables user choice for solid tumor, heme comprehensive genomic p...

Imprimen modelos tumorales en 3D con células reales de cáncer de mama para el ensayo de fármacos

by CIC biomaGUNE

9 months ago
tumores en 3D, cáncer de mama, organoides

Un grupo de CIC biomaGUNE fabrica modelos de tumores para entender cómo crecen y se comportan en distintas condiciones

Diseñan un dispositivo a escala celular que convierte el movimiento en electricidad para estimular células

by CSIC - Centro Superior de Investigaciones Científicas

9 months ago
estimulación celular, microdispositivo

Al estar hecho con un material que genera electricidad cuando se dobla, estira o comprime sin necesidad de cables ni baterías, puede colocarse sin cirugía profunda

Generative AI more efficient than nature at designing genome-editing proteins

by Centre for Genomic Regulation

9 months ago
transposases, PiggyBac, protein large language model (pLLM), Generative AI

It has been designed and experimentally validated new synthetic proteins that can edit the human genome more efficiently than proteins provided by nature that will be of great use in improving the cur...

What Role is Precision Medicine Playing in Transforming Cancer Treatment, and How Are Developers Adapting?

by Tebubio

9 months ago
Precision Medicine, CRISPR and mRNA

Precision medicine is redefining oncology by moving away from “one-size-fits-all” treatments towards therapies tailored to the unique genetic and molecular profile of each patient.

Nanoligent closes €12 million funding round to advance the development of its oncology nanodrug

by Nanoligent

9 months ago
Italian Angels for Growth, Nanoligent, i&i Bio, European Investment Fund, Clave Capital, CDTI Innovación, Inveready

Nanoligent is a company whose goal is to develop new anticancer drugs specifically targeting aggressive tumors, using a pioneering technological platform based on protein–drug nanoconjugates. The co...

Against melanoma

by Universitat Politècnica de València

9 months ago
Senescent cells, DPP4., melanoma

A team from the UPV leads the preclinical development of smart nanoparticles capable of eliminating tumour cells.

Reutilización de fármacos para cáncer de pulmón mediante estrategias computacionales

by Universidad Politécnica de Madrid

9 months ago
cáncer de pulmón no microcítico

Investigadores de la UPM lideran un trabajo que aplica una nueva tecnología de análisis computacional a las proteínas del cáncer buscando posibilidades de fármacos ya existentes.